Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls

SIMPLE SUMMARY: Genomic profiling of non-small cell lung cancer (NSCLC) patients offers the possibility of therapeutic intervention with target-based agents. The analysis of circulating free DNA (cfDNA) through next generation sequencing (NGS) technologies is emerging as a powerful tool to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito Abate, Riziero, Frezzetti, Daniela, Maiello, Monica Rosaria, Gallo, Marianna, Camerlingo, Rosa, De Luca, Antonella, De Cecio, Rossella, Morabito, Alessandro, Normanno, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766403/
https://www.ncbi.nlm.nih.gov/pubmed/33348595
http://dx.doi.org/10.3390/cancers12123804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766403/
https://www.ncbi.nlm.nih.gov/pubmed/33348595
http://dx.doi.org/10.3390/cancers12123804

Ejemplares similares